SCHEMBL5255389

SCHEMBL5255389

CCN(C(=O)CC1CCNCC1)C1CCNCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 9/20 0.40
SLC6A2 P23975 8/20 0.40
SLC6A3 Q01959 7/20 0.40
KCNH2 Q12809 3/20 0.40
SLC6A1 P30531 2/20 0.38
GABRA5 P31644 2/20 0.38
GABRB2 P47870 2/20 0.38
SLC6A12 P48065 2/20 0.38
SLC6A11 P48066 2/20 0.38
SLC6A13 Q9NSD5 2/20 0.38
GABRA1 P14867 1/20 0.38
GABRR1 P24046 1/20 0.38
GABRA4 P48169 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
EPHX1 P07099 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
GNAI3 P08754 1/20 0.36
GNAO1 P09471 1/20 0.36
GNAI1 P63096 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6967580 0.84 SLC6A4 (0.52) SLC6A4SLC6A2SLC6A3KCNH2L3MBTL1
SCHEMBL6969342 0.81 SLC6A4 (0.47) SLC6A4SLC6A2SLC6A3KCNH2L3MBTL1
SCHEMBL1290745 0.80 SLC6A4 (0.42) SLC6A4SLC6A2SLC6A3KCNH2GABRA5
SCHEMBL4912629 0.79 GPR119 (0.42) EPHX1
SCHEMBL297266 0.78 SLC6A4 (0.49) SLC6A4SLC6A2SLC6A3KCNH2GABRA5
SCHEMBL27348780 0.77 SLC6A4 (0.40) SLC6A4SLC6A2SLC6A3KCNH2GABRA5
Hydrochloric Acid SCHEMBL3740415 0.77 SLC6A4 (0.48) SLC6A4SLC6A2SLC6A3KCNH2GABRA5
SCHEMBL8851041 0.76 SLC6A4 (0.48) SLC6A4SLC6A2SLC6A3KCNH2
SCHEMBL9732660 0.76 GABRA5 (0.44) SLC6A1GABRA5GABRB2SLC6A12SLC6A11
SCHEMBL18928228 0.76 SLC6A4 (0.38) SLC6A4SLC6A2SLC6A3KCNH2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1833792-A1 SUBSTITUTED PIPERIDINE COMPOUNDS FOR USE AS CCR5 MODULATORS AstraZeneca AB (SE) 2007-09-19 EP disclosed
WO-2006067385-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2006-06-29 WO disclosed